CytoMed Therapeutics Ltd (GDTC)
2.11
-0.02
(-0.94%)
USD |
NASDAQ |
May 17, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
CytoMed Therapeutics Enterprise Value: 17.99M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 17.99M |
| May 16, 2024 | 18.10M |
| May 15, 2024 | 19.55M |
| May 14, 2024 | 17.41M |
| May 13, 2024 | 17.99M |
| May 10, 2024 | 18.10M |
| May 09, 2024 | 18.01M |
| May 08, 2024 | 18.45M |
| May 07, 2024 | 17.18M |
| May 06, 2024 | 18.39M |
| May 03, 2024 | 17.24M |
| May 02, 2024 | 17.76M |
| May 01, 2024 | 18.22M |
| April 30, 2024 | 17.87M |
| April 29, 2024 | 18.97M |
| April 26, 2024 | 17.76M |
| April 25, 2024 | 18.91M |
| April 24, 2024 | 18.33M |
| April 23, 2024 | 18.33M |
| April 22, 2024 | 19.49M |
| April 19, 2024 | 17.64M |
| April 18, 2024 | 17.62M |
| April 17, 2024 | 17.39M |
| April 16, 2024 | 17.97M |
| April 15, 2024 | 16.81M |
| Date | Value |
|---|---|
| April 12, 2024 | 17.73M |
| April 11, 2024 | 17.79M |
| April 10, 2024 | 17.27M |
| April 09, 2024 | 17.04M |
| April 08, 2024 | 17.04M |
| April 05, 2024 | 16.58M |
| April 04, 2024 | 17.16M |
| April 03, 2024 | 17.85M |
| April 02, 2024 | 17.50M |
| April 01, 2024 | 19.35M |
| March 28, 2024 | 18.54M |
| March 27, 2024 | 19.35M |
| March 26, 2024 | 17.62M |
| March 25, 2024 | 18.89M |
| March 22, 2024 | 19.58M |
| March 21, 2024 | 19.81M |
| March 20, 2024 | 20.73M |
| March 19, 2024 | 22.35M |
| March 18, 2024 | 19.46M |
| March 15, 2024 | 18.08M |
| March 14, 2024 | 18.20M |
| March 13, 2024 | 17.39M |
| March 12, 2024 | 17.39M |
| March 11, 2024 | 17.39M |
| March 08, 2024 | 17.27M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.58M
Minimum
Feb 28 2024
57.67M
Maximum
Jul 11 2023
32.10M
Average
34.03M
Median
Aug 22 2023
Enterprise Value Benchmarks
| Haw Par Corp Ltd | -853.06M |
| WAVE Life Sciences Ltd | 585.68M |
| ASLAN Pharmaceuticals Ltd | 18.16M |
| EUDA Health Holdings Ltd | -- |
| Mobile-health Network Solutions | -- |
Enterprise Value Related Metrics
| Earnings Yield | -13.69% |